Addex Therapeutics LtdADXNNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank21
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P21
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | -53.84% |
| 2023 | -88.04% |
| 2022 | -12.54% |
| 2021 | -13.10% |
| 2020 | -16.71% |
| 2019 | 425.82% |
| 2018 | 181.52% |
| 2017 | 2.68% |
| 2016 | 7.63% |
| 2015 | 194.98% |